According to the research report titled ‘North America Immunohematology Market Share By Technology, Product, End Use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2026’, available with Market Study Report, North America immunohematology market is expected to cross a valuation of USD 1,084.5 million by the year 2026.
 

High occurrence of blood disorders such as anemia, HIV, etc. in tandem with rising geriatric population are key factors driving the growth of North America immunohematology market. Increasing consumption of tobacco and rising adoption of smoking is further aiding the market expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2609875/
 

Technological advancements and rising number of trauma center and blood banks are also facilitating the business scenario in North America. However, strict regulatory scenario associated with immunohematology and lack of skilled professionals may hamper the industry remuneration in the forthcoming years.
 

Based on product landscape, reagents segment of North America immunohematology market is anticipated to experience a y-o-y growth rate of 5.7% and generate revenues worth USD 710.9 million by the year 2026. Increasing utilization of reagents for testing blood in diagnostic laboratories and in hospitals are fueling the segmental share.
 

Moving on to technology type, North America immunohematology market share from gel cards segment is expected to grow with a CAGR of 6% through 2026. Increasing awareness pertaining to advantages of gel cards such as better stability, ability to record, less time consuming and sensitive coupled with their widespread adoption for identifying antibodies is favoring the market outlook.
 

Citing the end-use landscape, hospitals segment held 53.8% market share in the year 2019 and is expected to register significant growth in the ensuing years. Rising adoption of hematology-based instruments including reagents and analyzers in hospitals is subsequently facilitating the growth of immunohematology market in North America.
 

Regionally, U.S. currently accounts for a substantial market share and is poised to accumulate similar returns in the forthcoming years. Meanwhile, Canada immunohematology market is predicted to expand with a CAGR of 5.8% through 2026. Escalating healthcare expenditure and growing population of baby boomers are swaying the business dynamics in Canada.
 

Immucor Inc., Roche Diagnostics, Hologic Inc., Grifols S.A., Diagast SAS, Bio-Rad Laboratories Inc., ANTISEL S.A., Beckman Coulter Inc., Becton Dickinson & Co., and Abott Laboratories are the key participants in North America immunohematology market.